180 Life Sciences Corp.

NASDAQ: ATNF · Real-Time Price · USD
7.09
-0.52 (-6.83%)
At close: Aug 15, 2025, 3:59 PM
7.20
1.55%
After-hours: Aug 15, 2025, 07:58 PM EDT

180 Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-6.17M -19.94M -38.73M -20.32M
Depreciation & Amortization
58.28K 105.67K 109K 109.95K
Stock-Based Compensation
308.17K 2.28M 2.97M 5M
Other Working Capital
1.56M -300.51K 1.51M -3.08M
Other Non-Cash Items
2.88M 8.99M 21.74M 4.67M
Deferred Income Tax
-292.42K -2.35M -942.75K -24.8K
Change in Working Capital
1.73M -14.1K 2.72M -8.81M
Operating Cash Flow
-1.48M -10.92M -12.13M -19.37M
Capital Expenditures
n/a 3.00 n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a -3 n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
-1.33M -288.07K -611.42K 800.85K
Common Stock Repurchased
n/a n/a -1.01M n/a
Dividend Paid
-8.01M n/a n/a n/a
Other Financial Acitivies
10.81M 196.47K 413.00 -2.06M
Financial Cash Flow
4.04M 5.91M 10.87M 25.41M
Net Cash Flow
2.61M -4.99M -1.25M 6.12M
Free Cash Flow
-1.48M -10.92M -12.13M -19.37M